NexGel Inc (NXGL)
NXGL trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1468929/000149315226014377/0001493152-26-014377-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | NXGL on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001468929 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $11.4M |
| Net income | -$3.0M |
| Operating income | -$3.4M |
| Net margin | -26.3% |
| Operating margin | -29.3% |
| Revenue growth | +31.5% |
| Cash | $317K |
| Total assets | $10.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions raise substantial doubt about the Company's ability to continue as a going concern." | 10-Q 2026-08-17 |
| Cash and burn | $1.7M cash; operating cash flow -$801K a quarter. | Report 2026-06-30 |
| Shares outstanding | 487,383 (2026-08-14); 8,067,580 a year earlier; 5,696,064 three years earlier. | Cover page 2026-08-14 |
| Reverse splits, 3 years | 1; latest 1-for-20 on 2026-10-12 | Source 2026-10-12 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 1 424B5 takedowns | Latest 2026-02-10 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-04-24 |
| Auditor | Turner, Stone & Company, L.L.P., Dallas, Texas, United States | PCAOB Form AP 2026-04-10 |
| Late filings, 12 months | 1 NT notice | NT 10-Q 2026-08-17 |
| Insider trades, 12 months | Bought $0, sold $77K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $3.7M | -$3.6M | -$2.2M | $1.7M | $3.2M | $12.1M | 10-Q 2026-08-17 |
| Q1 2026 2026-03-31 | $2.6M | -$927K | -$504K | $2.1M | $563K | $11.3M | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $2.8M | -$970K | $281K | $317K | $588K | $11.4M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $2.9M | -$653K | -$785K | $938K | $614K | $11.7M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $2.9M | -$665K | -$407K | $725K | $638K | $11.7M | 10-Q 2026-08-17 |
| Q1 2025 2025-03-31 | $2.8M | -$712K | -$400K | $1.2M | $662K | $10.2M | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $3.0M | -$850K | -$859K | $1.8M | $685K | $8.7M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $2.9M | -$693K | -$1.2M | $1.1M | $1.1M | $6.7M | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-08-20 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-16 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEF 14A | 2026-08-24 |
Source: SEC EDGAR submissions feed, 333 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +7.8% |
| 1 month | -4.2% |
| 3 months | -60.3% |
| Year to date | -88.0% |
| 1 year | -89.8% |
| From 52-week high | -89.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| NXGLW | NexGel Inc Warrant | $0.0065 |
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AMIX | Autonomix Medical Inc. | $1.10 | -19.71% | $2.2M |
| CODX | Co-Diagnostics Inc. | $0.2249 | -13.03% | $2.4M |
| BJDX | Bluejay Diagnostics Inc. | $2.29 | -12.26% | $2.6M |
| ICCM | IceCure Medical Ltd. | $0.7601 | +4.12% | $2.6M |
| IVF | INVO Fertility Inc. | $2.40 | -7.69% | $2.8M |
| VVOS | Vivos Therapeutics Inc. | $0.0822 | -16.12% | $2.8M |
| XAIR | Beyond Air Inc. | $2.02 | -5.16% | $3.4M |
| TNON | Tenon Medical Inc. | $1.33 | -5.32% | $3.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier